Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
- PMID: 31308580
- PMCID: PMC6598782
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
Abstract
Objectives: To examine the efficacy of lithium as a mood stabilizer for patients with autism spectrum disorder (ASD).
Experimental design: A retrospective chart review was performed that examined the use of both extended and immediate release lithium carbonate in patients with ASD that were treated at a single clinical center (CNNH NeuroHealth). Clinical Global Impression (CGI) scales were used to quantify baseline severity of ASD and mood symptoms as well as improvement after treatment with lithium carbonate.
Principle observations: Our retrospective chart review found that 73.7% (n = 14) of patients with ASD and concomitant maladaptive behaviors experienced "improvement" (CGI-I rating ≤ 3) with the addition of lithium to their treatment regimen. Those with comorbid "ADHD" phenotype were most predictive of an efficacious response (p = 0.038, Odds Ratio 12.2).
Conclusions: Lithium carbonate is a viable, efficacious and well tolerated alternative to various neuroleptics and other psychotropic medications for use as a mood stabilizer for patients with ASD.
Keywords: adhd; aggression; autism; autism spectrum disorder; bipolar; irritability; lithium; mood stabilization; obsessive compulsive disorder; self-injury.
Conflict of interest statement
Conflict of Interest The Authors declare that there are no conflicts of interest for the subject matter of this manuscript.
Figures
Similar articles
-
Post-acute effectiveness of lithium in pediatric bipolar I disorder.J Child Adolesc Psychopharmacol. 2013 Mar;23(2):80-90. doi: 10.1089/cap.2012.0063. J Child Adolesc Psychopharmacol. 2013. PMID: 23510444 Free PMC article. Clinical Trial.
-
Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder.J Child Adolesc Psychopharmacol. 2014 Sep;24(7):399-402. doi: 10.1089/cap.2014.0019. Epub 2014 Aug 5. J Child Adolesc Psychopharmacol. 2014. PMID: 25093602
-
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?Am J Psychiatry. 2005 Jan;162(1):137-45. doi: 10.1176/appi.ajp.162.1.137. Am J Psychiatry. 2005. PMID: 15625212 Clinical Trial.
-
Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.Clin Neuropharmacol. 2015 Sep-Oct;38(5):177-82. doi: 10.1097/WNF.0000000000000096. Clin Neuropharmacol. 2015. PMID: 26366961 Review.
-
Algorithms for the pharmacotherapy of bipolar disorder.Psychiatry Clin Neurosci. 1999 Oct;53 Suppl:S41-4. Psychiatry Clin Neurosci. 1999. PMID: 10560897 Review.
Cited by
-
Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium.Mol Psychiatry. 2024 Mar;29(3):704-717. doi: 10.1038/s41380-023-02362-y. Epub 2023 Dec 20. Mol Psychiatry. 2024. PMID: 38123724 Free PMC article.
-
Microdose Lithium Treatment Reduced Inflammatory Factors and Neurodegeneration in Organotypic Hippocampal Culture of Old SAMP-8 Mice.Cell Mol Neurobiol. 2021 Oct;41(7):1509-1520. doi: 10.1007/s10571-020-00916-0. Epub 2020 Jul 8. Cell Mol Neurobiol. 2021. PMID: 32642922 Free PMC article.
-
Extended-Release Lithium Treatment for Adolescents with Bipolar Disorder with or Without Comorbid Autism Spectrum Disorder: Protocol of a Longitudinal Prospective Naturalistic Study for the Assessment of Efficacy and Tolerability.J Clin Med. 2024 Oct 17;13(20):6196. doi: 10.3390/jcm13206196. J Clin Med. 2024. PMID: 39458145 Free PMC article.
-
Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.J Autism Dev Disord. 2021 Dec;51(12):4370-4394. doi: 10.1007/s10803-021-05237-9. Epub 2021 Sep 7. J Autism Dev Disord. 2021. PMID: 34491511
-
Effects of lithium on mortality and metabolite profiles in Drosophila lithium-inducible SLC6 transporter mutants.Environ Toxicol Pharmacol. 2025 Jun;116:104684. doi: 10.1016/j.etap.2025.104684. Epub 2025 Apr 5. Environ Toxicol Pharmacol. 2025. PMID: 40194719
References
-
- Guzzetta F, Tondo L, Centorrino F, Baldessarini R. Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder. J Clin Psychiatry. 2007;68:380–383. - PubMed
-
- Malone R, Delaney M, Luebbert J, Cater J, Campbell M. A Double-Blind Placebo-Controlled Study of Lithium in Hospitalized Aggressive Children and Adolescents With Conduct Disorder. Arch Gen Psychiatry. 2000;57:649–654. - PubMed
-
- Baldessarini R, Tondo L. Does Lithium Treatment Still Work? Evidence of Stable Responses Over Three Decades. Arch Gen Psychiatry. 2000;57:187–190. - PubMed
-
- Corbella B, Vieta E. Molecular targets of lithium action. Acta Psychiatr Scand. 2003;15:316–340. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical